ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,876Medicare Part D Prescriptions Filled, Including Refills

Rank: 327 out of 972

$448K Total Retail Price of All Prescriptions

Rank: 376 out of 972

510 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,366 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 360 303 1 1
OMEPRAZOLE 318 304 2 5
LEVOTHYROXINE SODIUM 281 274 3 3
WARFARIN SODIUM 255 254 4 12
ATORVASTATIN CALCIUM 246 239 5 11
AMLODIPINE BESYLATE 244 241 6 4
TRIAMTERENE-HCTZ 237 228 7 39
SIMVASTATIN 193 188 8 2
SERTRALINE HCL 181 180 9 25
TRAMADOL HCL 178 168 10 15
METFORMIN HCL 166 144 11 8
FUROSEMIDE 159 159 12 7
HYDROCODONE-ACETAMINOPHEN 146 119 S3 13 6
LOSARTAN POTASSIUM 139 139 14 17
PRAVASTATIN SODIUM 128 124 15 20
METOPROLOL TARTRATE 125 109 16 9
ESCITALOPRAM OXALATE 125 124 16 65
SYNTHROID 117 94 18 51
ATENOLOL 116 116 19 18
METOPROLOL SUCCINATE 110 110 20 16
MELOXICAM 104 96 21 36
DONEPEZIL HCL 95 95 22 26
PANTOPRAZOLE SODIUM 94 90 23 41
CARVEDILOL 93 88 24 21
ALLOPURINOL 91 89 25 28
HYDROCHLOROTHIAZIDE 85 75 26 10
INDAPAMIDE 85 76 26 188
PENTOXIFYLLINE 83 75 28 342
SPIRONOLACTONE 75 75 29 54
POTASSIUM CHLORIDE 75 65 29 13
CLOPIDOGREL 73 73 31 37
ZOLPIDEM TARTRATE 69 68 32 23
PLAVIX 67 67 33 55
BENICAR 67 67 33 133
GLIMEPIRIDE 63 59 35 34
VERAPAMIL ER 63 61 35 108
METHYLPREDNISOLONE 62 59 37 119
BUMETANIDE 57 57 38 173
AZITHROMYCIN 57 57 38 42
PAROXETINE HCL 55 43 40 64
GABAPENTIN 55 55 40 14
ISOSORBIDE MONONITRATE ER 54 54 42 43
TAMSULOSIN HCL 52 52 43 29
PREMARIN 52 51 R 43 153
CYCLOBENZAPRINE HCL 51 48 R 45 53
CITALOPRAM HBR 50 43 46 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.